A Role for Cellular Prion Protein in Late-Onset Alzheimer's Disease: Evidence from Preclinical Studies

Overview

Journal J Neurosci

Specialty Neurology

Date 2018 Mar 2

PMID 29491138

Citations 3

Authors

Ricardo A S Lima-Filho

Mauricio M Oliveira

Affiliations

Soon will be listed here.

Citing Articles

The Role of the JAK/STAT Signaling Pathway in the Pathogenesis of Alzheimer's Disease: New Potential Treatment Target.

Rusek M, Smith J, El-Khatib K, Aikins K, Czuczwar S, Pluta R Int J Mol Sci. 2023; 24(1).

PMID: 36614305 PMC: 9821184. DOI: 10.3390/ijms24010864.

Understanding and exploiting interactions between cellular proteostasis pathways and infectious prion proteins for therapeutic benefit.

Yakubu U, Catumbela C, Morales R, Morano K Open Biol. 2020; 10(11):200282.

PMID: 33234071 PMC: 7729027. DOI: 10.1098/rsob.200282.

Molecular Pathogenesis and Interventional Strategies for Alzheimer's Disease: Promises and Pitfalls.

Bhute S, Sarmah D, Datta A, Rane P, Shard A, Goswami A ACS Pharmacol Transl Sci. 2020; 3(3):472-488.

PMID: 32566913 PMC: 7296537. DOI: 10.1021/acsptsci.9b00104.

References

Mallucci G, Ratte S, Asante E, Linehan J, Gowland I, Jefferys J . Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration. EMBO J. 2002; 21(3):202-10. PMC: 125833. DOI: 10.1093/emboj/21.3.202. View

Terry R, Masliah E, Salmon D, Butters N, DeTeresa R, Hill R . Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol. 1991; 30(4):572-80. DOI: 10.1002/ana.410300410. View

Linden R, Martins V, Prado M, Cammarota M, Izquierdo I, Brentani R . Physiology of the prion protein. Physiol Rev. 2008; 88(2):673-728. DOI: 10.1152/physrev.00007.2007. View

Lauren J, Gimbel D, Nygaard H, Gilbert J, Strittmatter S . Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature. 2009; 457(7233):1128-32. PMC: 2748841. DOI: 10.1038/nature07761. View

Balducci C, Beeg M, Stravalaci M, Bastone A, Sclip A, Biasini E . Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein. Proc Natl Acad Sci U S A. 2010; 107(5):2295-300. PMC: 2836680. DOI: 10.1073/pnas.0911829107. View

Gimbel D, Nygaard H, Coffey E, Gunther E, Lauren J, Gimbel Z . Memory impairment in transgenic Alzheimer mice requires cellular prion protein. J Neurosci. 2010; 30(18):6367-74. PMC: 3323924. DOI: 10.1523/JNEUROSCI.0395-10.2010. View

Masliah E, Terry R, Mallory M, Alford M, Hansen L . Diffuse plaques do not accentuate synapse loss in Alzheimer's disease. Am J Pathol. 1990; 137(6):1293-7. PMC: 1877714. View

Bjorklund N, Reese L, Sadagoparamanujam V, Ghirardi V, Woltjer R, Taglialatela G . Absence of amyloid β oligomers at the postsynapse and regulated synaptic Zn2+ in cognitively intact aged individuals with Alzheimer's disease neuropathology. Mol Neurodegener. 2012; 7:23. PMC: 3403985. DOI: 10.1186/1750-1326-7-23. View

Um J, Nygaard H, Heiss J, Kostylev M, Stagi M, Vortmeyer A . Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Nat Neurosci. 2012; 15(9):1227-35. PMC: 3431439. DOI: 10.1038/nn.3178. View

10.

Um J, Kaufman A, Kostylev M, Heiss J, Stagi M, Takahashi H . Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer aβ oligomer bound to cellular prion protein. Neuron. 2013; 79(5):887-902. PMC: 3768018. DOI: 10.1016/j.neuron.2013.06.036. View

11.

Hu N, Nicoll A, Zhang D, Mably A, OMalley T, Purro S . mGlu5 receptors and cellular prion protein mediate amyloid-β-facilitated synaptic long-term depression in vivo. Nat Commun. 2014; 5:3374. PMC: 4354159. DOI: 10.1038/ncomms4374. View

12.

Haas L, Kostylev M, Strittmatter S . Therapeutic molecules and endogenous ligands regulate the interaction between brain cellular prion protein (PrPC) and metabotropic glutamate receptor 5 (mGluR5). J Biol Chem. 2014; 289(41):28460-77. PMC: 4192497. DOI: 10.1074/jbc.M114.584342. View

13.

Kaufman A, Salazar S, Haas L, Yang J, Kostylev M, Jeng A . Fyn inhibition rescues established memory and synapse loss in Alzheimer mice. Ann Neurol. 2015; 77(6):953-71. PMC: 4447598. DOI: 10.1002/ana.24394. View

14.

Ferreira S, Lourenco M, Oliveira M, De Felice F . Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer's disease. Front Cell Neurosci. 2015; 9:191. PMC: 4443025. DOI: 10.3389/fncel.2015.00191. View

15.

Bilousova T, Miller C, Poon W, Vinters H, Corrada M, Kawas C . Synaptic Amyloid-β Oligomers Precede p-Tau and Differentiate High Pathology Control Cases. Am J Pathol. 2016; 186(1):185-98. PMC: 4715217. DOI: 10.1016/j.ajpath.2015.09.018. View

16.

Hong S, Beja-Glasser V, Nfonoyim B, Frouin A, Li S, Ramakrishnan S . Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science. 2016; 352(6286):712-716. PMC: 5094372. DOI: 10.1126/science.aad8373. View

17.

Woodling N, Colas D, Wang Q, Minhas P, Panchal M, Liang X . Cyclooxygenase inhibition targets neurons to prevent early behavioural decline in Alzheimer's disease model mice. Brain. 2016; 139(Pt 7):2063-81. PMC: 4939702. DOI: 10.1093/brain/aww117. View

18.

Haas L, Strittmatter S . Oligomers of Amyloid β Prevent Physiological Activation of the Cellular Prion Protein-Metabotropic Glutamate Receptor 5 Complex by Glutamate in Alzheimer Disease. J Biol Chem. 2016; 291(33):17112-21. PMC: 5016115. DOI: 10.1074/jbc.M116.720664. View

19.

Beraldo F, Ostapchenko V, Caetano F, Guimaraes A, Ferretti G, Daude N . Regulation of Amyloid β Oligomer Binding to Neurons and Neurotoxicity by the Prion Protein-mGluR5 Complex. J Biol Chem. 2016; 291(42):21945-21955. PMC: 5063978. DOI: 10.1074/jbc.M116.738286. View

20.

. 2016 Alzheimer's disease facts and figures. Alzheimers Dement. 2016; 12(4):459-509. DOI: 10.1016/j.jalz.2016.03.001. View